花园生物: 第七届董事会第十二次会议决议公告

Meeting Overview - The seventh board meeting of Zhejiang Huayuan Biological Pharmaceutical Co., Ltd. was held on September 2, 2025, with all nine directors present, and the meeting complied with relevant laws and regulations [1][2]. Resolutions Passed - The board approved the election of Mr. Shao Xujun as the representative director to execute company affairs and serve as the legal representative, with a term lasting until the end of the seventh board's term. The voting results were 9 votes in favor, 0 against, and 0 abstentions [1]. - The board also approved the election of members for the audit committee, including Mr. Shao Xujun, Mr. Yan Jianmiao, and Mr. Li Guowei, with Mr. Li Guowei designated as the committee convener. The term for the audit committee members is the same as that of the seventh board [2]. Background of Elected Members - Mr. Shao Xujun has extensive experience within the Huayuan Group and holds 2.45425 million shares of the company. He is the son-in-law of the actual controller, Mr. Shao Qinxiang, and has not faced any penalties from regulatory bodies [2]. - Mr. Yan Jianmiao is a professor at Zhejiang University and has no shareholding in the company, with no conflicts of interest with major shareholders or management [3]. - Mr. Li Guowei is a professor at Zhejiang University of Finance and Economics and also has no shareholding in the company, maintaining independence from major stakeholders [3][4].